Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
6,586 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.
Howard-Anderson J, Hamasaki T, Ge L, Collyar D, Cosgrove SE, Doernberg SB, Geres H, Gopinath R, Holland TL, King HA, Nambiar S, Rubin D, Chambers HF, Fowler VG, Evans SR, Boucher HW. · Open Forum Infect Dis · 2026 · cited 3 timesOpen accessclinical trial
- Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis.
Kong WQ, Shu YF, Tang J, Li SQ, Zhong H, Zhang XY. · BMC Infect Dis · 2025 · cited 1 timesOpen accesssystematic review, review-article
- Efficacy and safety of tedizolid in the treatment of acute bacterial skin and skin-structure infections: a systematic review and meta-analysis of randomised controlled trials.
Sevilla P, Martínez A, Pérez-Olaso O, Camarena JJ. · Clin Microbiol Infect · 2026 · cited 1 timesmeta-analysis, systematic review
- A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections.
Sutton KN, Lydon E, Rader A, Barton KD, Skalla LA, Wang TW, Ruffin F, Oakes M, Miller J, Collyar D, Boucher HW, Doernberg SB, King HA. · Clin Infect Dis · 2025 · cited 4 timessystematic review, research support, n.i.h., extramural
- A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections.
Mngqibisa R, Fofanov O, Grazioso CF, Melgar Toledo M, Boddicker M, Broyde N, Koseoglu S, Romero L, Stevens M, Sears P. · Pediatr Infect Dis J · 2025 · cited 4 timesOpen accessclinical trial, phase iii, comparative study
- Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA.
Pardos SL, Hope W, Kotsaki A, Das S, Giamarellos-Bourboulis EJ, Kontopoulouk T, Akinosoglou K, O'Hare M, Attwood MLG, Bowker KE, Noel AR, Lovering AM, Bayliss MAJ, Evans RN, MacGowan AP. · J Antimicrob Chemother · 2024 · cited 2 timesresearch support, non-u.s. gov't, randomized controlled trial
- Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections.
Bhavnani SM, Hammel JP, Lakota EA, Liolios K, Trang M, Rubino CM, Steenbergen JN, Friedrich L, Tzanis E, Ambrose PG. · Antimicrob Agents Chemother · 2024 · cited 3 timesOpen accessclinical trial, phase iii, research support, non-u.s. gov't
- The Safety and Efficacy of Dalbavancin and Active Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections.
Giorgobiani M, Burroughs MH, Antadze T, Carrothers TJ, Riccobene TA, Patel R, Lin T, Stefanova P. · Pediatr Infect Dis J · 2023 · cited 19 timesOpen accessresearch support, non-u.s. gov't, multicenter study
- Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis.
Vlachaki I, Vacchelli M, Zinzi D, Falla E, Jiang Y, Mantopoulos T, Nathwani D. · BMC Infect Dis · 2021 · cited 8 timesOpen accesssystematic review, network meta-analysis
- Efficacy and safety of oritavancin for the treatment of acute bacterial skin and skin-structure infections: a systematic review and meta-analysis.
Zhang H, Zhou W, Wang J, Cai Y. · J Glob Antimicrob Resist · 2021 · cited 8 timesmeta-analysis, research support, non-u.s. gov't
- Clinical efficacy and safety of novel lipoglycopeptides in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials.
Hsu CK, Chen CY, Chen WC, Chao CM, Lai CC. · Expert Rev Anti Infect Ther · 2022 · cited 2 timesmeta-analysis, systematic review
- Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis.
Monteagudo-Martínez N, Solís-García Del Pozo J, Nava E, Ikuta I, Galindo M, Jordán J. · Expert Rev Anti Infect Ther · 2022 · cited 12 timesmeta-analysis, research support, non-u.s. gov't
- Omadacycline for Acute Bacterial Skin and Skin Structure Infections.
Abrahamian FM, Sakoulas G, Tzanis E, Manley A, Steenbergen J, Das AF, Eckburg PB, McGovern PC. · Clin Infect Dis · 2019 · cited 32 timesOpen accessclinical trial, phase iii, research support, non-u.s. gov't
- Omadacycline for Acute Bacterial Skin and Skin-Structure Infections.
O'Riordan W, Green S, Overcash JS, Puljiz I, Metallidis S, Gardovskis J, Garrity-Ryan L, Das AF, Tzanis E, Eckburg PB, Manley A, Villano SA, Steenbergen JN, Loh E. · N Engl J Med · 2019 · cited 124 timesclinical trial, phase iii, comparative study
- Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
Overcash JS, Kim C, Keech R, Gumenchuk I, Ninov B, Gonzalez-Rojas Y, Waters M, Simeonov S, Engelhardt M, Saulay M, Ionescu D, Smart JI, Jones ME, Hamed KA. · Clin Infect Dis · 2021 · cited 47 timesOpen accessclinical trial, phase iii, research support, u.s. gov't, p.h.s.
- Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.
Bradley JS, Antadze T, Ninov B, Tayob MS, Broyde N, Butterton JR, Chou MZ, De Anda CS, Kim JY, Sears PS. · Pediatr Infect Dis J · 2021 · cited 13 timesclinical trial, phase iii, research support, non-u.s. gov't
- Afabicin, a First-in-Class Antistaphylococcal Antibiotic, in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Clinical Noninferiority to Vancomycin/Linezolid.
Wittke F, Vincent C, Chen J, Heller B, Kabler H, Overcash JS, Leylavergne F, Dieppois G. · Antimicrob Agents Chemother · 2020 · cited 59 timesOpen accessresearch support, non-u.s. gov't, multicenter study
- Ceftaroline and ceftobiprole monotherapy for the treatment of Staphylococcus aureus infections: a systematic review and Bayesian meta-analysis.
Rando E, Magrini E, Sangiorgi F, Salvati F, Catania F, Chiuchiarelli M, Matteini E, Fantoni M, Torti C, López-Cortés LE, Rodríguez-Baño J, Murri R. · J Antimicrob Chemother · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.
Giordano PA, Pogue JM, Cammarata S. · Clin Infect Dis · 2019 · cited 16 timesOpen accessclinical trial, phase iii, multicenter study
- Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections.
Rappo U, Gonzalez PL, Puttagunta S, Akinapelli K, Keyloun K, Gillard P, Liu Y, Dunne MW. · J Glob Antimicrob Resist · 2019 · cited 35 timesclinical trial, phase iii, research support, non-u.s. gov't
- Analysis of Pooled Phase 3 Safety Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections.
Bassetti M, Hooper D, Tillotson G. · Clin Infect Dis · 2019 · cited 14 timesOpen accessclinical trial, phase iii
- Efficacy and Safety of a Novel Broad-Spectrum Anti-MRSA Agent Levonadifloxacin Compared with Linezolid for Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Openlabel, Randomized Study.
Bhatia A, Mastim M, Shah M, Gutte R, Joshi P, Kumbhar D, Periasamy H, Palwe SR, Chavan R, Bhagwat S, Patel M, Llorens L, Friedland HD. · J Assoc Physicians India · 2020 · cited 13 timesclinical trial, phase iii, equivalence trial
- Effect of Cold Atmospheric Plasma on Wound Healing in a Standardized Wound Model-A Prospective, Monocentric, Self-Controlled Clinical Trial.
Geber B, Landscheidt K, Goertz O. · Int Wound J · 2026 · cited 0 timesOpen accessrandomized controlled trial
- IL-17 ligand-targeting inhibitors in psoriatic arthritis: a focused systematic review and network meta-analysis of efficacy, safety, and certainty of evidence.
AbuJwaid YK, Assi AK, Amro AM, Awwad HH, Ehmidat M, Deeb S, Awlad Mohammad MW, Dwayat A, Odeh A, Albow Y, Yasini M, Alfrookh M, Alamlih L. · Front Immunol · 2026 · cited 0 timesOpen accesssystematic review, systematic-review
- Predictive Models for Medical Adhesive-Related Skin Injury: A Systematic Review and Meta-Analysis.
Gu Y, Lu Z, Zhao Y, Fan S, Xie J. · Nurs Open · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.